Leede Jones Gab Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leede Jones Gab. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leede Jones Gab.

CompanyDateActionBrokerageRatingPrice TargetImpact on PriceActions
Liminal BioSciences logo
LMNL
Liminal BioSciences
3/26/2021Reiterated byLeede Jones GabHoldLow    
K-Bro Linen logo
KBL
K-Bro Linen
3/19/2021Reiterated byLeede Jones GabBuyN/A    
IMV logo
IMV
IMV
3/18/2021Reiterated byLeede Jones GabSpeculative BuyN/A    
Cipher Pharmaceuticals logo
CPH
Cipher Pharmaceuticals
3/22/2021Upgraded byLeede Jones GabSpeculative Buy -> BuyN/A    
IMV logo
IMV
IMV
3/18/2021Reiterated byLeede Jones GabSpeculative BuyHigh    
Medical Facilities logo
DR
Medical Facilities
3/12/2021Reiterated byLeede Jones GabBuyN/A    
Profound Medical logo
PRN
Profound Medical
3/4/2021Reiterated byLeede Jones GabBuyN/A    
Profound Medical logo
PROF
Profound Medical
3/4/2021Reiterated byLeede Jones GabBuyMedium    
Extendicare logo
EXE
Extendicare
3/1/2021Reiterated byLeede Jones GabBuyN/A    
Theratechnologies logo
THTX
Theratechnologies
2/26/2021Downgraded byLeede Jones GabSpeculative Buy -> HoldLow    
Theratechnologies logo
TH
Theratechnologies
2/26/2021Downgraded byLeede Jones GabSpeculative Buy -> HoldN/A    
ONC
Oncolytics Biotech
2/24/2021Reiterated byLeede Jones GabSpeculative BuyN/A    
Oncolytics Biotech logo
ONCY
Oncolytics Biotech
2/24/2021Reiterated byLeede Jones GabSpeculative BuyHigh    
CSV / Excel Export To export this table to CSV or Excel, upgrade to MarketBeat All Access.

MarketBeat Community Rating for Leede Jones Gab

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  17
MarketBeat's community ratings are surveys of what our community members think about Leede Jones Gab and other research firms. Vote "Outperform" if you believe Leede Jones Gab's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leede Jones Gab's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.